Top 100 Contractors in PSC 65: Medical/Dental/Veterinary Equipment/Supplies, FY2023

Parent companies by net contract obligations Oct 1, 2022 – Sep 30, 2023 Code page on GovTribe

The top 10 won 72% of FY2023 PSC 65 contract dollars

Ranking facts

Contract obligations
$24,977,336,088 Net of deobligations, by contracts coded PSC 65 or a code under it
Contractors
3,798 Parent companies with an obligation
Largest contractor
Mckesson Corporation $10.2 billion, 39.4% of obligations
Data as of

Contract actions from FPDS (SAM.gov). How the rankings work · Download all 100 rows as CSV

Full ranking

Rank Contractor Net obligations Share Trend
1 $10,153,453,448
Rank history: #2 in FY2021, #2 in FY2022, #1 in FY2024 and #1 in FY2025; up 1 since FY2022.
2 $2,247,616,940
Rank history: not on the FY2021 list, #14 in FY2022, #3 in FY2024 and not on the FY2025 list; up 12 since FY2022.
3 $2,134,927,736
Rank history: #5 in FY2021, #7 in FY2022, #2 in FY2024 and #2 in FY2025; up 4 since FY2022.
4 $1,871,734,144
Rank history: #1 in FY2021, #1 in FY2022 and not on the FY2024–FY2025 lists; down 3 since FY2022.
5 $644,247,481
Rank history: #8 in FY2021, #11 in FY2022, #11 in FY2024 and not on the FY2025 list; up 6 since FY2022.
6 $336,129,869
Rank history: #11 in FY2021, #16 in FY2022, #6 in FY2024 and #3 in FY2025; up 10 since FY2022.
7 $308,641,784
Rank history: #16 in FY2021, #8 in FY2022 and not on the FY2024–FY2025 lists; up 1 since FY2022.
8 $256,620,000
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; new.
9 $255,622,571
Rank history: #13 in FY2021, #17 in FY2022, #9 in FY2024 and #5 in FY2025; up 8 since FY2022.
10 $246,837,992
Rank history: #12 in FY2021, #31 in FY2022 and not on the FY2024–FY2025 lists; up 21 since FY2022.
11 $245,429,824
Rank history: #17 in FY2021, #20 in FY2022, #7 in FY2024 and not on the FY2025 list; up 9 since FY2022.
12 $237,000,000
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; new.
13 $204,186,055
Rank history: not on the FY2021–FY2022 lists, #8 in FY2024 and #10 in FY2025; new.
14 $202,000,951
Rank history: #14 in FY2021, #18 in FY2022, #12 in FY2024 and #8 in FY2025; up 4 since FY2022.
15 $178,372,187
Rank history: #19 in FY2021, #10 in FY2022, #68 in FY2024 and not on the FY2025 list; down 5 since FY2022.
16 $167,771,279
Rank history: #45 in FY2021, #23 in FY2022, #13 in FY2024 and #13 in FY2025; up 7 since FY2022.
17 $150,026,231
Rank history: #96 in FY2021, not on the FY2022 list and not on the FY2024–FY2025 lists; returned.
18 $149,566,718
Rank history: #21 in FY2021, not on the FY2022 list, #50 in FY2024 and not on the FY2025 list; returned.
19 $148,558,159
Rank history: #78 in FY2021, #58 in FY2022, #42 in FY2024 and not on the FY2025 list; up 39 since FY2022.
20 $146,399,515
Rank history: #75 in FY2021, #28 in FY2022, #15 in FY2024 and #12 in FY2025; up 8 since FY2022.
21 $144,561,565
Rank history: #23 in FY2021, #21 in FY2022, #16 in FY2024 and #16 in FY2025; unchanged since FY2022.
22 $135,454,000
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; new.
23 $127,679,897
Rank history: #61 in FY2021, #12 in FY2022, #79 in FY2024 and not on the FY2025 list; down 11 since FY2022.
24 $125,526,228
Rank history: #28 in FY2021, #15 in FY2022, #10 in FY2024 and #14 in FY2025; down 9 since FY2022.
25 $97,614,023
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; up 77 since FY2022.
26 $95,607,285
Rank history: #36 in FY2021, #30 in FY2022, #22 in FY2024 and #20 in FY2025; up 4 since FY2022.
27 $88,807,712
Rank history: #43 in FY2021, #33 in FY2022, #24 in FY2024 and #19 in FY2025; up 6 since FY2022.
28 $81,801,863
Rank history: #47 in FY2021, #34 in FY2022 and not on the FY2024–FY2025 lists; up 6 since FY2022.
29
William Demants OG Hustru IDA Emilies (MILLAS) Fond - Kaldet 7 awardees, including Oticon, Inc., E3 Diagnostics, Inc. and Oticon Medical LLC
$76,507,987
Rank history: #71 in FY2021, #47 in FY2022, #72 in FY2024 and not on the FY2025 list; up 18 since FY2022.
30 $74,962,236
Rank history: #84 in FY2021, #76 in FY2022, #90 in FY2024 and not on the FY2025 list; up 46 since FY2022.
31 $71,025,328
Rank history: #41 in FY2021, #46 in FY2022, #31 in FY2024 and #25 in FY2025; up 15 since FY2022.
32 $63,792,353
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; new.
33 $62,078,897
Rank history: not on the FY2021–FY2022 lists, #36 in FY2024 and not on the FY2025 list; up 147 since FY2022.
34 $61,130,121
Rank history: #29 in FY2021, #41 in FY2022, #44 in FY2024 and #44 in FY2025; up 7 since FY2022.
35 $57,762,541
Rank history: #42 in FY2021, #49 in FY2022, #48 in FY2024 and #48 in FY2025; up 14 since FY2022.
36 $55,347,415
Rank history: #51 in FY2021, #53 in FY2022, #38 in FY2024 and #23 in FY2025; up 17 since FY2022.
37 $54,911,137
Rank history: #20 in FY2021, #69 in FY2022, #61 in FY2024 and #40 in FY2025; up 32 since FY2022.
38
Spectral MD Inc.
$54,903,264
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; new.
39 $48,403,222
Rank history: #40 in FY2021, #40 in FY2022, #34 in FY2024 and #31 in FY2025; up 1 since FY2022.
40 $47,446,914
Rank history: #49 in FY2021, #39 in FY2022, #25 in FY2024 and #67 in FY2025; down 1 since FY2022.
41 $46,691,330
Rank history: #57 in FY2021, #79 in FY2022, not on the FY2024 list and #76 in FY2025; up 38 since FY2022.
42 $46,183,723
Rank history: #55 in FY2021, #56 in FY2022, #47 in FY2024 and #49 in FY2025; up 14 since FY2022.
43 $45,310,198
Rank history: #58 in FY2021, #59 in FY2022 and not on the FY2024–FY2025 lists; up 16 since FY2022.
44 $44,636,781
Rank history: #67 in FY2021, #68 in FY2022, #40 in FY2024 and #33 in FY2025; up 24 since FY2022.
45 $43,984,321
Rank history: #65 in FY2021, #67 in FY2022, #70 in FY2024 and not on the FY2025 list; up 22 since FY2022.
46 $36,767,159
Rank history: #73 in FY2021, #75 in FY2022, #57 in FY2024 and #38 in FY2025; up 29 since FY2022.
47 $36,430,079
Rank history: #38 in FY2021, #45 in FY2022, #49 in FY2024 and #29 in FY2025; down 2 since FY2022.
48 $36,398,440
Rank history: #76 in FY2021, not on the FY2022 list, #81 in FY2024 and not on the FY2025 list; returned.
49 $36,268,302
Rank history: not on the FY2021 list, #55 in FY2022, #18 in FY2024 and #26 in FY2025; up 6 since FY2022.
50
Teva Pharmaceutical Industries Ltd. Through Teva Pharmaceuticals Usa, Inc.
$36,142,176
Rank history: #63 in FY2021, #60 in FY2022 and not on the FY2024–FY2025 lists; up 10 since FY2022.
51 $35,383,741
Rank history: #77 in FY2021, not on the FY2022 list, #46 in FY2024 and #52 in FY2025; up 90 since FY2022.
52 $33,287,326
Rank history: #62 in FY2021, #99 in FY2022, #75 in FY2024 and #99 in FY2025; up 47 since FY2022.
53 $33,219,488
Rank history: #7 in FY2021, #9 in FY2022 and not on the FY2024–FY2025 lists; down 44 since FY2022.
54 $31,269,985
Rank history: #39 in FY2021, #27 in FY2022, #93 in FY2024 and #27 in FY2025; down 27 since FY2022.
55 $30,636,697
Rank history: #85 in FY2021, #62 in FY2022 and not on the FY2024–FY2025 lists; up 7 since FY2022.
56 $30,158,750
Rank history: #94 in FY2021, #74 in FY2022 and not on the FY2024–FY2025 lists; up 18 since FY2022.
57 $29,539,909
Rank history: #70 in FY2021, #93 in FY2022 and not on the FY2024–FY2025 lists; up 36 since FY2022.
58 $28,627,390
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; up 60 since FY2022.
59 $28,586,802
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; up 103 since FY2022.
60 $28,474,525
Rank history: not on the FY2021 list, #71 in FY2022 and not on the FY2024–FY2025 lists; up 11 since FY2022.
61 $28,100,603
Rank history: #60 in FY2021, #64 in FY2022 and not on the FY2024–FY2025 lists; up 3 since FY2022.
62 $27,283,173
Rank history: not on the FY2021 list, #26 in FY2022, not on the FY2024 list and #34 in FY2025; down 36 since FY2022.
63 $27,229,450
Rank history: #82 in FY2021, #82 in FY2022 and not on the FY2024–FY2025 lists; up 19 since FY2022.
64 $26,325,396
Rank history: not on the FY2021–FY2022 lists, #60 in FY2024 and #47 in FY2025; up 44 since FY2022.
65 $26,066,372
Rank history: #74 in FY2021, #61 in FY2022, #80 in FY2024 and not on the FY2025 list; down 4 since FY2022.
66
Investor AB Through Permobil Inc.
$25,615,043
Rank history: not on the FY2021–FY2022 lists, #55 in FY2024 and not on the FY2025 list; up 193 since FY2022.
67 $24,941,740
Rank history: #90 in FY2021, #63 in FY2022 and not on the FY2024–FY2025 lists; down 4 since FY2022.
68 $24,805,892
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; up 38 since FY2022.
69 $24,804,773
Rank history: #81 in FY2021, #57 in FY2022 and not on the FY2024–FY2025 lists; down 12 since FY2022.
70 $24,254,835
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; up 41 since FY2022.
71 $23,699,744
Rank history: not on the FY2021–FY2022 lists, #82 in FY2024 and #88 in FY2025; up 147 since FY2022.
72 $23,086,277
Rank history: not on the FY2021 list, #87 in FY2022, #73 in FY2024 and #69 in FY2025; up 15 since FY2022.
73 $23,027,695
Rank history: not on the FY2021 list, #88 in FY2022 and not on the FY2024–FY2025 lists; up 15 since FY2022.
74 $22,199,262
Rank history: not on the FY2021 list, #44 in FY2022, #71 in FY2024 and #41 in FY2025; down 30 since FY2022.
75 $22,042,463
Rank history: #93 in FY2021, #95 in FY2022 and not on the FY2024–FY2025 lists; up 20 since FY2022.
76 $22,016,031
Rank history: not on the FY2021–FY2022 lists, #67 in FY2024 and not on the FY2025 list; up 80 since FY2022.
77 $21,358,317
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; new.
78 $21,151,537
Rank history: not on the FY2021–FY2022 lists, not on the FY2024 list and #92 in FY2025; up 32 since FY2022.
79 $20,957,351
Rank history: not on the FY2021 list, #72 in FY2022, #62 in FY2024 and #73 in FY2025; down 7 since FY2022.
80 $20,640,839
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; up 25 since FY2022.
81 $20,474,625
Rank history: #15 in FY2021, #85 in FY2022 and not on the FY2024–FY2025 lists; up 4 since FY2022.
82 $19,334,788
Rank history: #87 in FY2021, #89 in FY2022, not on the FY2024 list and #79 in FY2025; up 7 since FY2022.
83 $19,258,916
Rank history: #88 in FY2021, #81 in FY2022 and not on the FY2024–FY2025 lists; down 2 since FY2022.
84 $17,441,447
Rank history: #97 in FY2021, #94 in FY2022 and not on the FY2024–FY2025 lists; up 10 since FY2022.
85 $16,776,275
Rank history: not on the FY2021 list, #92 in FY2022 and not on the FY2024–FY2025 lists; up 7 since FY2022.
86 $16,259,781
Rank history: not on the FY2021 list, #86 in FY2022 and not on the FY2024–FY2025 lists; unchanged since FY2022.
87 $16,247,335
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; up 35 since FY2022.
88
Biofactura Inc
$16,243,348
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; new.
89 $16,112,925
Rank history: #80 in FY2021, #37 in FY2022, #29 in FY2024 and #50 in FY2025; down 52 since FY2022.
90 $16,074,408
Rank history: not on the FY2021 list, #96 in FY2022, #100 in FY2024 and #80 in FY2025; up 6 since FY2022.
91 $15,635,719
Rank history: #89 in FY2021, #73 in FY2022, #94 in FY2024 and not on the FY2025 list; down 18 since FY2022.
92 $15,456,551
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; up 33 since FY2022.
93 $15,446,399
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; new.
94 $15,064,809
Rank history: not on the FY2021 list, #90 in FY2022 and not on the FY2024–FY2025 lists; down 4 since FY2022.
95 $14,682,352
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; up 149 since FY2022.
96 $14,584,925
Rank history: not on the FY2021 list, #100 in FY2022 and not on the FY2024–FY2025 lists; up 4 since FY2022.
97
Boehringer Ingelheim Corporation 2 awardees, including Boehringer Ingelheim Animal Health France
$14,362,467
Rank history: #98 in FY2021, #84 in FY2022 and not on the FY2024–FY2025 lists; down 13 since FY2022.
98 $13,420,489
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; up 225 since FY2022.
99 $13,270,926
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; up 62 since FY2022.
100 $12,415,993
Rank history: not on the FY2021–FY2022 lists, not on the FY2024 list and #11 in FY2025; up 44 since FY2022.
Show 75 more

100 of 3,798 contractors listed here. See the rest on GovTribe.

Rankings for the codes under PSC 65

Code Net obligations Largest contractor
6505 Drugs and Biologicals $17,678,295,372 Mckesson Corporation
6515 Medical and Surgical Instruments, Equipment, and Supplies $4,660,693,405 Cardinal Health, Inc.
6550 In Vitro Diagnostic Substances, Reagents, Test Kits and Sets $1,071,091,876 Abbott Laboratories
6525 X-Ray Equipment and Supplies: Medical, Dental, Veterinary $1,004,976,140 Siemens Aktiengesellschaft
6530 Hospital Furniture, Equipment, Utensils, and Supplies $379,335,264 Arthrex Inc.
6540 Ophthalmic Instruments, Equipment, and Supplies $67,407,417 PDS Consultants, Inc.
6545 Replenishable Field Medical Sets, Kits, and Outfits $58,448,319 Southeastern Kentucky Rehabilitation Industries, Inc.
6520 Dental Instruments, Equipment, and Supplies $33,400,534 A-Dec Inc.
6532 Hospital and Surgical Clothing and Related Special Purpose Items $8,960,164 LC Industries Inc.
6510 Surgical Dressing Materials $8,228,217 Cardinal Health, Inc.
6509 Drugs and Biologicals, Veterinary Use $6,232,806 Boehringer Ingelheim Corporation

How this ranking works

  • Source: every contract action FPDS records (as published on SAM.gov) in the period, as GovTribe received it.
  • Amounts are net obligations: what was obligated, less what was deobligated. Shares are of $25.8 billion obligated before deobligations, so they never pass 100%.
  • Parent companies: each action counts under the ultimate parent its award record names, or under the awardee when it names none, so no dollar counts twice. Parents of the same name (Inc., LLC and the like aside) count as one company, since FPDS records a company's parent under more than one UEI over time. GovTribe corrects a few parents and names by hand; see the corrections.
  • Fiscal year 2023 ran Oct 1, 2022 – Sep 30, 2023. The Department of Defense reports its contract actions to FPDS about 90 days late, so a fiscal year is ranked once they're in, in February, and the list doesn't change after.
  • Rank changes compare with FY2022. "New" marks a company outside that period's top 500, and "Returned" one of those that was on an earlier fiscal year's list.
  • Rank lines show each company's rank on every fiscal year's list since FY2021, #1 at the top, on a scale that gives the top of the list more room. A dashed stretch spans years it wasn't on the list. The step from FY2022 takes the color of the rank change beside it.
  • Placeholder recipients FPDS uses when it names no company ("Miscellaneous Foreign Contractors" and the like) aren't ranked.

Quick answers

Who were the top 10 PSC 65 contractors in FY2023?

1. Mckesson Corporation ($10.2B), 2. Amerisourcebergen Corporation ($2.25B), 3. Cencora, Inc. ($2.13B), 4. Pfizer Inc. ($1.87B), 5. Cardinal Health, Inc. ($644M), 6. Medline Industries, LP ($336M), 7. Abbott Laboratories ($309M), 8. New York Embroidery Studio Inc. ($257M), 9. DMS Pharmaceutical Group Inc. ($256M), 10. Emergent Biosolutions Inc. ($247M).

On GovTribe

Research every contractor on this list

  • Every contract, task order and IDV they hold
  • Their subsidiaries, teammates and competitors
  • Open opportunities they're positioned for
  • Alerts when they win new work